Signaturefd, LLC Fate Therapeutics Inc Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Signaturefd, LLC holds 422 shares of FATE stock, worth $936. This represents 0.0% of its overall portfolio holdings.

Number of Shares

422

Previous 475 11.16%

Holding current value

$936

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$3.12 - $5.57 $165 - $295	-53 Reduced 11.16%	422 $1,000
Q2 2024 Jul 29, 2024	SELL	$3.26 - $7.08 $1,264 - $2,747	-388 Reduced 44.96%	475 $1,000
Q1 2024 May 03, 2024	BUY	$3.54 - $8.35 $1,780 - $4,200	503 Added 139.72%	863 $6,000
Q4 2023 Jan 31, 2024	SELL	$1.65 - $3.94 $1,029 - $2,458	-624 Reduced 63.41%	360 $1,000
Q3 2023 Nov 03, 2023	SELL	$2.02 - $5.04 $6,201 - $15,472	-3,070 Reduced 75.73%	984 $2,000
Q2 2023 Aug 01, 2023	BUY	$4.76 - $6.59 $4,069 - $5,634	855 Added 26.73%	4,054 $19,000
Q1 2023 Apr 28, 2023	BUY	$4.24 - $11.12 $3,892 - $10,208	918 Added 40.25%	3,199 $18,000
Q4 2022 Jan 27, 2023	BUY	$9.86 - $23.83 $11,141 - $26,927	1,130 Added 98.18%	2,281 $23,000
Q3 2022 Nov 08, 2022	BUY	$21.04 - $36.06 $1,704 - $2,920	81 Added 7.57%	1,151 $26,000
Q2 2022 Aug 10, 2022	BUY	$17.78 - $42.39 $3,538 - $8,435	199 Added 22.85%	1,070 $27,000
Q1 2022 May 02, 2022	BUY	$29.67 - $60.28 $8,396 - $17,059	283 Added 48.13%	871 $34,000
Q4 2021 Jan 25, 2022	SELL	$47.84 - $64.34 $14,973 - $20,138	-313 Reduced 34.74%	588 $34,000
Q3 2021 Oct 28, 2021	SELL	$59.27 - $95.73 $355 - $574	-6 Reduced 0.66%	901 $53,000
Q2 2021 Jul 26, 2021	BUY	$67.25 - $92.52 $48,083 - $66,151	715 Added 372.4%	907 $79,000
Q4 2020 Feb 11, 2021	SELL	$38.09 - $100.95 $418 - $1,110	-11 Reduced 5.42%	192 $17,000
Q3 2020 Nov 03, 2020	BUY	$30.41 - $40.5 $1,459 - $1,944	48 Added 30.97%	203 $8,000
Q1 2020 Apr 23, 2020	BUY	$17.28 - $31.88 $2,678 - $4,941	155 New	155 $3,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $215M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account